NO20000066L - 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse - Google Patents
6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelseInfo
- Publication number
- NO20000066L NO20000066L NO20000066A NO20000066A NO20000066L NO 20000066 L NO20000066 L NO 20000066L NO 20000066 A NO20000066 A NO 20000066A NO 20000066 A NO20000066 A NO 20000066A NO 20000066 L NO20000066 L NO 20000066L
- Authority
- NO
- Norway
- Prior art keywords
- ylpyrindine
- pyrrolidin
- derivatives
- preparation
- pharmaceutical use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Oppfinnelsen vedrører en forbindelse med generell formel (I) hvor Ri representerer et hydrogenatom, en (C1-C4) -alkylgruppe eller en f enyl (C^-C^) -alkylgruppe, som eventuelt er substituert, R2 representerer et hydrogenatom eller en (C1-C4) -alkylgruppe, og R 09 Rs representerer hver et hydrogenatom eller halogenatom, eller en trif luormetylgruppe, cyanogruppe, hydroksylgruppe, "(C^-Cg) -alkylgruppe eller (C^-Cg) - alkoksygruppe . Oppfinnelsen har terapeutisk anvendelse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9708706A FR2765874B1 (fr) | 1997-07-09 | 1997-07-09 | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique |
PCT/FR1998/001446 WO1999002517A1 (fr) | 1997-07-09 | 1998-07-07 | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000066D0 NO20000066D0 (no) | 2000-01-06 |
NO20000066L true NO20000066L (no) | 2000-03-09 |
Family
ID=9509040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000066A NO20000066L (no) | 1997-07-09 | 2000-01-06 | 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse |
Country Status (21)
Country | Link |
---|---|
US (1) | US6184229B1 (no) |
EP (1) | EP1000056A1 (no) |
JP (1) | JP2002508004A (no) |
KR (1) | KR20010021617A (no) |
CN (1) | CN1262680A (no) |
AR (1) | AR013192A1 (no) |
AU (1) | AU8544498A (no) |
BG (1) | BG104037A (no) |
BR (1) | BR9811672A (no) |
CA (1) | CA2295666A1 (no) |
CO (1) | CO4890850A1 (no) |
EE (1) | EE200000018A (no) |
FR (1) | FR2765874B1 (no) |
HU (1) | HUP0003856A2 (no) |
IL (1) | IL133536A0 (no) |
NO (1) | NO20000066L (no) |
PL (1) | PL338123A1 (no) |
SK (1) | SK212000A3 (no) |
TR (1) | TR200000057T2 (no) |
WO (1) | WO1999002517A1 (no) |
ZA (1) | ZA986047B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005126340A (ja) * | 2003-10-22 | 2005-05-19 | Kureha Chem Ind Co Ltd | 置換ピリドン類の製造法、その原料化合物及びその製造方法 |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
KR20110075044A (ko) | 2007-04-02 | 2011-07-05 | 파킨슨즈 인스티튜트 | 처치 치료의 부작용을 감소시키기 위한 방법 및 조성물 |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227391A (en) * | 1992-04-10 | 1993-07-13 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5232933A (en) * | 1992-05-21 | 1993-08-03 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
-
1997
- 1997-07-09 FR FR9708706A patent/FR2765874B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-07 SK SK21-2000A patent/SK212000A3/sk unknown
- 1998-07-07 US US09/462,352 patent/US6184229B1/en not_active Expired - Fee Related
- 1998-07-07 JP JP50824799A patent/JP2002508004A/ja active Pending
- 1998-07-07 BR BR9811672-0A patent/BR9811672A/pt not_active IP Right Cessation
- 1998-07-07 WO PCT/FR1998/001446 patent/WO1999002517A1/fr not_active Application Discontinuation
- 1998-07-07 EP EP98936453A patent/EP1000056A1/fr not_active Withdrawn
- 1998-07-07 PL PL98338123A patent/PL338123A1/xx unknown
- 1998-07-07 CN CN98807003A patent/CN1262680A/zh active Pending
- 1998-07-07 HU HU0003856A patent/HUP0003856A2/hu unknown
- 1998-07-07 CA CA002295666A patent/CA2295666A1/en not_active Abandoned
- 1998-07-07 EE EEP200000018A patent/EE200000018A/xx unknown
- 1998-07-07 AU AU85444/98A patent/AU8544498A/en not_active Abandoned
- 1998-07-07 KR KR1020007000175A patent/KR20010021617A/ko not_active Application Discontinuation
- 1998-07-07 IL IL13353698A patent/IL133536A0/xx unknown
- 1998-07-07 TR TR2000/00057T patent/TR200000057T2/xx unknown
- 1998-07-08 AR ARP980103305A patent/AR013192A1/es not_active Application Discontinuation
- 1998-07-08 ZA ZA986047A patent/ZA986047B/xx unknown
- 1998-07-08 CO CO98038696A patent/CO4890850A1/es unknown
-
1999
- 1999-12-22 BG BG104037A patent/BG104037A/xx unknown
-
2000
- 2000-01-06 NO NO20000066A patent/NO20000066L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE200000018A (et) | 2000-08-15 |
AU8544498A (en) | 1999-02-08 |
JP2002508004A (ja) | 2002-03-12 |
TR200000057T2 (tr) | 2000-08-21 |
FR2765874B1 (fr) | 1999-08-13 |
EP1000056A1 (fr) | 2000-05-17 |
CN1262680A (zh) | 2000-08-09 |
CO4890850A1 (es) | 2000-02-28 |
NO20000066D0 (no) | 2000-01-06 |
WO1999002517A1 (fr) | 1999-01-21 |
CA2295666A1 (en) | 1999-01-21 |
FR2765874A1 (fr) | 1999-01-15 |
HUP0003856A2 (hu) | 2001-10-28 |
US6184229B1 (en) | 2001-02-06 |
BG104037A (en) | 2001-04-30 |
SK212000A3 (en) | 2000-06-12 |
IL133536A0 (en) | 2001-04-30 |
BR9811672A (pt) | 2000-09-19 |
PL338123A1 (en) | 2000-09-25 |
AR013192A1 (es) | 2000-12-13 |
KR20010021617A (ko) | 2001-03-15 |
ZA986047B (en) | 1999-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1257553T3 (da) | Pyrrolopyrimidinonderivater, fremgangsmåder til fremstilling og anvendelse | |
DK0595851T3 (da) | Fremgangsmåde til fremstilling af sertralin-mellemprodukter | |
DK1131315T3 (da) | Polyhydroxylerede heterocykliske derivater som antikoagulanter | |
DK405786D0 (da) | Nitromethylenderivater, deres fremstilling og anvendelse | |
BR9610385A (pt) | Novas 4-(oxalcoxifenil)-3-óxi-piperidinas para tratamento de insuficiência cardiáca e renal | |
NO20045331L (no) | Piperazinylacylpiperidinderivater, deres fremstilling og terapeutisk anvendelse derav | |
IT1232252B (it) | Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione | |
ATE356624T1 (de) | Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung | |
DE69231445T2 (de) | Triazole enthaltende antifungizide mittel | |
DK1222159T3 (da) | Mellemprodukter til fremstilling af et benzofuran- eller benzothiophenderivat, som er nitreret i position 5, og anvendelse heraf | |
NO20000066L (no) | 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse | |
DK0623121T3 (da) | Fremstilling af N-acetylneuraminsyrederivater | |
ATE15890T1 (de) | Ein fungizides indanylbenzamid. | |
NO993109L (no) | Aromatiske aminderivater med NOS inhiberende effekt | |
DE3776044D1 (de) | Pyridazinon-derivate. | |
NO961404L (no) | 4-indolylpiperazinyl-derivater | |
BR9609991A (pt) | Carbamoilcarboxamida composição adequada para controlar fungos nocivos processos para a preparação de uma carbamoilcarboxamida para preparação da composição e para controle de fungos nocivos e uso de um composto ou de uma composição | |
DK546286D0 (da) | Piperidinderivater eller salte deraf og deres anvendelse som farmaceutika | |
DK437287D0 (da) | 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater | |
DE69510510T2 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
NO20000423D0 (no) | Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene | |
BR0206206A (pt) | Derivados de etoposide e análogos, e composições farmacêuticas contendo os mesmos | |
SE8605458D0 (sv) | 4-hydroxycoumarin derivatives | |
DK37582A (da) | 2-pyridyloxyacetanilider,fremgangsmaade til deres fremstillingsamt deres anvendelse som herbicider | |
EE9900238A (et) | Difenüülalküültetrahüdropüridiinid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |